North Andover, MA, United States of America

Mary Beth Switzer

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 9.2

ph-index = 2

Forward Citations = 100(Granted Patents)


Company Filing History:


Years Active: 2011-2020

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Journey of Mary Beth Switzer

Introduction

Mary Beth Switzer, a distinguished inventor based in North Andover, MA, has made significant contributions to the field of biotechnology. With a total of three patents to her name, her work primarily focuses on advancements in clotting factor purification and chromatography methods, showcasing her expertise and innovation in the scientific community.

Latest Patents

Among her recent inventions, one notable patent is titled "Methods for purifying FXa variant proteins." This invention encompasses compositions comprising recombinant variants of human clotting Factor Xa, which have a variety of isoforms and post-translational modifications. These compositions are particularly useful for treating subjects in need of hemostasis. Additionally, she holds a patent for the "Method of weak partitioning chromatography," which details innovative methods for purifying a product from a load fluid that contains impurities. This method is distinguished by specific operating conditions that enhance the binding capacity of the purification medium.

Career Highlights

Throughout her career, Mary Beth Switzer has been associated with renowned organizations such as Wyeth and Pfizer Corporation. Her role in these companies has helped propel her work into practical applications, impacting the biotechnology industry positively.

Collaborations

Mary has worked alongside esteemed colleagues, including Brian D. Kelley and James Edward Booth. Their collaborative efforts have contributed to the successful development and realization of innovative projects in the field, reinforcing the importance of teamwork in scientific discovery.

Conclusion

In conclusion, Mary Beth Switzer exemplifies the spirit of innovation and dedication in biotechnology. Her patents demonstrate her commitment to advancing medical science through inventive solutions. As she continues her work, her contributions will undoubtedly play a vital role in shaping the future of treatments related to hemostasis and protein purification.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…